Skip to main content
. 2013 Apr 2;8(4):e60113. doi: 10.1371/journal.pone.0060113

Table 5. SMA-MAP analytes and their correlated outcomes.

Analyte Correlated Outcome Measures
APOB CMAP, Strength
APCS Motor
ASHG Motor, PD, CMAP, Strength
AXL FVC, Motor, PD?, PQP
CCL2 PD?
CD93 Motor, MUNE, PQC, Strength
CFH Motor
CDH13 Motor
CHI3L1 Motor
CLEC3B Motor, PQC
COMP Motor, MUNE, Strength
CRP Motor, PD?
CTSD Motor
DPP4 Motor, MUNE, PQP, Strength
ENG Motor, PD?
ERBB2 CHOP-TOSS, Motor, PD?
FBLN1 FVC, Motor, PD?, Strength
IGF1 PD?
IGFBP6 Motor, PD?
LEP Motor
LUM CMAP, Motor, MUNE, PD? Strength
MB FVC, Motor, Strength
PEPD CMAP, Motor, MUNE, Strength
PGF Motor, MUNE, PD?
SPP1 Motor
THBS4 Motor, MUNE, PD?
TNXB Motor

CHOP-TOSS = Children’s Hospital of Philadelphia Test of Strength, FVC = forced vital capacity, Motor = motor function scale (e.g. MHFMS, HFMS, HFMSE, GMFM), PD = SMN pharmacodynamic measure, CMAP = compound motor action potential, MUNE = motor unit number estimation, PQP = PedQL quality of life, parent score, PQC = PedQL quality of life, child score, CHOP-TOSS = Children’s Hospital of Philadelphia Test of Strength.